Eswatini vs Hong Kong, China: Tuberculosis treatment success rate by type
Eswatini
83
in 2023
Hong Kong, China
82
in 2023
Eswatini rank
106th
Hong Kong, China rank
108th
Tuberculosis treatment success rate by type over time
- Eswatini
- Hong Kong, China
How they compare
Eswatini currently reports 83 against 82 in Hong Kong, China, a difference of 1.
The two have swapped places 1 time across 22 shared years of data; in 2001 it was Hong Kong, China ahead.
Eswatini ranks 106th and Hong Kong, China ranks 108th of 194 countries.
Across the 3 decades both report, Eswatini averaged higher in 2 and Hong Kong, China in 1.
Head to head by decade
| Decade | Eswatini | Hong Kong, China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.44 | 64.56 | 18.11 | Hong Kong, China |
| 2010s | 79.56 | 66.67 | 12.89 | Eswatini |
| 2020s | 81.5 | 77.25 | 4.25 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Eswatini or Hong Kong, China?
- Eswatini, at 83 against 82 in Hong Kong, China as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Eswatini and Hong Kong, China?
- 1, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Hong Kong, China?
- 22 years are reported by both, from 2001 to 2023.
- How do Eswatini and Hong Kong, China rank globally for tuberculosis treatment success rate by type?
- Eswatini ranks 106th and Hong Kong, China ranks 108th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.